查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2010028

內視鏡市場：2026-2032年全球市場預測（以內視鏡類型、易用性、影像技術、最終用戶和應用分類）

Endoscopy Market by Endoscope Type, Usability, Imaging Technology, End User, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025 年內視鏡市場價值 469.2 億美元，預計到 2026 年將成長至 504.5 億美元，複合年成長率為 7.99%，到 2032 年將達到 803.9 億美元。

主要市場統計數據
基準年 2025 469.2億美元
預計年份：2026年 504.5億美元
預測年份 2032 803.9億美元
複合年成長率 (%) 7.99%

為因應臨床需求、設備創新、安全要求和採購壓力，策略性因應措施正在重塑內視鏡的引進和採購決策過程。

內視鏡醫學的現狀正處於快速技術創新、臨床重點轉變以及對安全性和成本效益日益嚴格的監管三者交匯的階段。影像技術、一次性器材設計和感染控制方面的進步正在改變臨床醫生選擇設備的方式，以及醫療系統管理資本投資和營運成本的方式。隨著微創手術在各專科的診斷和治療路徑中不斷佔據基礎，內視鏡技術必須應對更嚴格的工作流程、不斷提高的診斷準確性要求以及不斷變化的監管環境。

技術整合、以安全為中心的產品設計以及供應鏈韌性如何重新定義內視鏡領域的競爭格局和臨床應用。

在內鏡領域，正在發生多項變革性變化，這些變化正在全面重塑競爭優勢和應用路徑。首先，一次性技術與可重複使用可用技術之間的平衡不再是階段性選擇，而是影響製造地、服務模式和臨床工作流程的策略軸心。一次性器材在設計和成本效益方面取得了進步，為旨在減輕再處理負擔和降低感染傳播風險的醫療機構創造了新的服務和採購模式。同時，影像技術、感測器精度和軟體改進方面的進步提高了診斷的可靠性，並推動了基於遠端醫療的影像診斷的發展。

本分析檢視了美國新關稅措施對醫療設備製造商和供應商的供應鏈、籌資策略和商業決策的策略性連鎖反應。

美國於2025年宣布的一系列關稅政策調整，正對內視鏡產業生態系統產生廣泛的下游影響。關稅導致的接收成本變化，影響製造商、醫院採購部門和第三方服務供應商，迫使相關人員重新評估籌資策略和營運模式。對於依賴國際供應鏈的醫療設備製造商而言，關稅政策直接促使他們重新審視零件採購管道，對新的供應商進行認證，或考慮將關鍵前置作業時間的生產外包到近岸地區，以降低進口風險並提高交貨週期的可預測性。

詳細的細分洞察解釋了設備類型、易用性、成像系統、醫療環境和臨床應用如何共同決定採購和開發重點。

細分市場趨勢揭示了臨床需求與技術能力的交會點，從而在不同的產品線和醫療環境中創造了差異化的機會。在評估內視鏡類型時，市場將內視鏡分為軟式內視鏡（包括支氣管鏡、大腸鏡、膀胱鏡、十二指腸鏡和胃鏡）和硬式內視鏡（包括關節鏡、子宮鏡和腹腔鏡）。臨床專科和手術量決定了醫療設備的需求。對於軟式內視鏡，導航、鏡端影像品質和用於治療性介入的通道功能是優先考慮的因素；而對於硬式內視鏡，手術環境下的光學清晰度、器械相容性和耐用性則更為重要。這些技術需求指南設計權衡和服務交付，製造商針對每種亞型最佳化滅菌相容性和配件生態系統。

區域趨勢和部署模式表明，美洲、歐洲、中東和非洲以及亞太地區都需要各自獨特的商業化、供應和服務策略。

區域趨勢影響全球內視鏡市場的需求模式和競爭格局。在美洲，醫療保健整合、報銷結構以及對價值醫療的重視，推動了人們對能夠提高診斷準確性並降低總手術成本的解決方案的興趣。安全性和可追溯性方面的監管預期，以及大規模的集中化（這些機構制定了採購標準），也影響著內視鏡技術的普及趨勢。因此，能夠提供整合服務模式和顯著感染控制優勢的公司，在採購談判中往往更具優勢。

競爭策略揭示了產品差異化、整合服務模式和數位化如何塑造供應商定位和夥伴關係活動。

醫療設備製造商和服務供應商之間的競爭圍繞著三大核心提案：產品性能差異化、服務和滅菌能力，以及數位化轉型。主要企業正投資於新一代光學技術、人體工學設計和通道多功能性，以提高診斷準確性和治療效率。他們也在拓展服務和再處理解決方案，以解決醫療服務提供者在處理能力、合規性和生命週期管理方面的擔憂。這種硬體與服務相結合的模式，透過維護和耗材供應契約，加強了客戶關係並創造了持續的收入。

為製造商和醫療保健系統領導者提供切實可行的策略行動，以保護供應鏈、加速臨床部署並創造永續的商業性優勢。

產業領導者應優先採取一系列具體行動，將策略洞察轉化為可衡量的成果。首先，應實現採購和供應鏈策略多元化，以減輕貿易政策干擾的影響，並縮短關鍵零件的前置作業時間。關鍵模組的近岸外包和雙重採購可以保持靈活性，並抵禦突如其來的關稅和物流中斷。其次，應加快開發和臨床檢驗能夠解決感染預防和再處理效率問題的解決方案，因為這些特性正日益影響所有醫療機構的採購決策。

一項穩健的混合方法研究，結合了初步的臨床和採購訪談、嚴格的二次分析和迭代的專家檢驗。

本執行摘要基於一項研究，該研究結合了對該領域專家的結構化一手訪談、對臨床文獻和監管指南的系統性回顧，以及對供應商和醫療服務提供者數據的檢驗，以檢驗研究結果。主要資訊來源包括對臨床醫生、醫院和門診中心的採購經理以及醫療設備製造商和分銷商的高階主管的訪談。這些對話對醫療器材的推廣應用促進因素、臨床限制和採購優先事項進行了定性評估。

結論強調，臨床創新、監管合規和強力的商業化之間的協調一致，將決定內視鏡領域的長期成功。

目前內視鏡領域既充滿機會也面臨挑戰。影像技術、醫療設備設計和數位分析技術的進步正在拓展臨床應用能力，並為提高診斷準確性鋪平道路。同時，安全問題、監管以及貿易政策的變化使得供應鏈韌性、生命週期思維和服務卓越性變得至關重要。醫療機構和製造商若能積極將產品創新與營運實際情況結合，尤其是在設備再處理能力、檢測處理能力和本地採購慣例，將取得最佳的應用效果。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 內視鏡市場：以內視鏡類型分類

  • 軟式內視鏡
    • 支氣管鏡檢查
    • 大腸鏡檢查
    • 膀胱鏡
    • 十二指腸內視鏡檢查
    • 胃鏡檢查
  • 硬式內視鏡
    • 關節鏡
    • 子宮鏡
    • 腹腔鏡

第9章：內視鏡市場：依易用性分類

  • 一次性的
  • 可重複使用的

第10章：依影像技術分類的內視鏡市場

  • 光纖內視鏡
  • 影像內視鏡

第11章 內視鏡市場：依最終用戶分類

  • 門診手術中心
  • 診所
  • 醫院

第12章 內視鏡市場：依應用領域分類

  • 消化系統
  • 婦科
  • 呼吸系統
  • 泌尿系統

第13章 內視鏡市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 內視鏡市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 內視鏡市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國內視鏡市場

第17章：中國內視鏡市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Ambu A/S
  • Arthrex, Inc.
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • CONMED Corporation
  • Cook Medical LLC
  • FUJIFILM Holdings Corporation
  • Hoya Corporation
  • Intuitive Surgical, Inc.
  • Johnson & Johnson
  • KARL STORZ SE & Co. KG
  • Medtronic plc
  • Mindray Medical International Limited
  • Olympus Corporation
  • Pentax Medical Company
  • Richard Wolf GmbH
  • Smith & Nephew plc
  • STERIS Corporation
  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-434CCDA04E9F

The Endoscopy Market was valued at USD 46.92 billion in 2025 and is projected to grow to USD 50.45 billion in 2026, with a CAGR of 7.99%, reaching USD 80.39 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 46.92 billion
Estimated Year [2026] USD 50.45 billion
Forecast Year [2032] USD 80.39 billion
CAGR (%) 7.99%

A strategic orientation to clinical needs, device innovation, safety imperatives, and procurement pressures that are reshaping endoscopy adoption and purchasing decisions

The modern endoscopy landscape sits at the convergence of rapid technological innovation, shifting clinical priorities, and heightened scrutiny around safety and cost-effectiveness. Advances in imaging, single-use device design, and infection prevention are changing the way clinicians choose instruments and how health systems manage capital and operational expenditures. As minimally invasive procedures continue to anchor diagnostic and therapeutic pathways across specialties, endoscopy technologies must respond to tighter workflows, greater demand for diagnostic accuracy, and evolving regulatory expectations.

Clinicians and administrators increasingly prioritize solutions that reduce procedural complexity and mitigate cross-contamination risk while preserving or enhancing image quality and therapeutic capability. Consequently, manufacturers are accelerating product upgrades that improve ergonomics, integrate digital imaging and analytics, and simplify reprocessing. At the same time, providers are balancing those clinical benefits with procurement realities, supply chain resilience, and lifecycle cost considerations. Together, these forces create a dynamic environment where device performance, infection control credentials, service infrastructure, and supply assurance influence procurement and adoption decisions.

Understanding these dynamics requires a holistic view of clinical need, device technology, and operational constraints. This report frames the critical intersections between clinical utility and commercial strategy, emphasizing practical implications for manufacturers, hospital systems, ambulatory centers, and clinical teams. By focusing on actionable intelligence that connects innovation to adoption enablers, the analysis highlights where investments and strategic shifts deliver the greatest clinical and economic returns.

How technological integration, safety-driven product design, and supply chain resilience are jointly redefining competitive models and clinical adoption in endoscopy

The endoscopy field is undergoing several transformative shifts that collectively reconfigure competitive advantage and adoption pathways. First, the balance between single-use and reusable technologies is no longer an incremental choice but a strategic axis that affects manufacturing footprints, service models, and clinical workflows. Single-use devices have advanced in design and cost-effectiveness, prompting new service and procurement models in facilities that aim to lower reprocessing burden and infection transmission risk. In parallel, improvements in video imaging, sensor fidelity, and software-driven enhancement are elevating diagnostic confidence and enabling telemedicine-enabled interpretations.

Second, integration of digital health capabilities is accelerating. Real-time image analytics, artificial intelligence-assisted lesion detection, and cloud-based case management systems are shifting value from hardware alone toward software-enabled diagnostic ecosystems. These shifts create opportunities for vendors to expand recurring revenue streams through software licensing, data services, and outcome-based contracting. Third, regulatory and reimbursement environments have tightened attention on safety, traceability, and environmental impact, prompting manufacturers and providers to re-evaluate lifecycle costs and cleaning protocols. Finally, supply chain resilience has moved to the forefront of strategic planning. Manufacturers and buyers are diversifying sourcing strategies, adopting dual-sourcing approaches, and re-examining onshore manufacturing to mitigate tariff exposure and logistics disruptions.

Taken together, these shifts mean that technical performance, digital integration, safety credentials, and supply assurance now determine market momentum. Strategic players that align product innovation with robust service and supply-chain propositions will find differentiated adoption opportunities across clinical settings.

Analyzing the strategic ripple effects of new U.S. tariff measures on supply chains, procurement strategies, and the operational calculus of device manufacturers and providers

The cumulative policy adjustments introduced through the United States tariffs announced in 2025 have broad downstream implications for the endoscopy ecosystem. Tariff-induced changes in landed costs affect manufacturers, hospital purchasing departments, and third-party service providers, compelling stakeholders to reassess sourcing strategies and operational models. For device producers reliant on transnational supply chains, tariffs create immediate incentives to review component sourcing, qualify new suppliers, or consider near-shoring for critical subassemblies to reduce import exposure and improve lead-time predictability.

Health systems and ambulatory providers respond to tariff-driven cost pressures through procurement levers, including renegotiated service agreements, longer-term purchase commitments, and a heightened focus on total cost of ownership rather than initial acquisition price. Capital-constrained facilities may delay elective upgrades or accelerate adoption of single-use products where reprocessing cost and sterilization capital make a compelling offset to import-related cost increases. At the same time, independent third-party service organizations and distributors adjust pricing and contractual terms to preserve margin while managing inventory risks and longer replenishment cycles.

Regulatory compliance and documentation burdens increase as manufacturers and providers validate alternative supplier sources and manufacturing locations. This process can extend time-to-market for new devices and complicate post-market surveillance. Yet, the tariff environment also stimulates strategic realignment: organizations that invest in regional manufacturing capability or stronger supply diversification gain competitive advantage through improved cost predictability and responsiveness. In short, tariffs amplify the need for agile procurement, deeper supplier collaboration, and portfolio strategies that account for evolving trade policy risks.

Deep segmentation insights explaining how device type, usability, imaging systems, care setting, and clinical application jointly determine procurement and development priorities

Segment-level dynamics reveal where clinical demand and technology capability intersect to create differentiated opportunities across product lines and care settings. When evaluating endoscope type, the market differentiates between flexible endoscopes, which include bronchoscopes, colonoscopes, cystoscopes, duodenoscopes, and gastroscopes, and rigid endoscopes, which encompass arthroscopes, hysteroscopes, and laparoscopes. Clinical specialties and procedural volumes shape device requirements: flexible endoscopes prioritize navigation, distal imaging quality, and channel functionality for therapeutic interventions, while rigid endoscopes emphasize optical clarity, instrument compatibility, and durability in operative environments. These technical needs inform design trade-offs and service offerings, with manufacturers tailoring sterilization compatibility and accessory ecosystems to each subtype.

Usability considerations-disposable versus reusable-drive procurement and operational choices across facilities. Disposable endoscopes reduce reprocessing complexity and mitigate cross-contamination concerns, making them attractive for lower-volume sites or procedures with high infection-control sensitivity. Conversely, reusable devices continue to appeal where durability, higher-performance optics, and cost amortization over repeated use align with institutional case-mix and sterilization capacity. The interplay between usability and imaging technology is critical: fiber optic systems retain advantages in specific legacy applications, whereas video endoscopy platforms enable higher-resolution imaging, easier integration with digital analytics, and smoother clinician adoption for image-driven diagnostics.

End users-ambulatory surgical centers, clinics, and hospitals-exhibit distinct procurement behaviors and clinical workflows that influence device selection. Ambulatory surgical centers often prioritize throughput, simplified reprocessing, and lower up-front capital, while clinics may emphasize portability and single-procedure cost-effectiveness. Hospitals routinely require comprehensive service agreements, interoperable IT integration, and devices that support a wide procedural spectrum. Across applications-gastrointestinal, gynecological, respiratory, and urological-the degree of therapeutic intervention, instrument channel needs, and imaging demands vary, which in turn shapes product road maps and aftermarket service propositions. Ultimately, success depends on aligning device attributes with procedural requirements, reprocessing infrastructure, and the economic model of each care setting.

Regional dynamics and adoption patterns showing how the Americas, Europe Middle East & Africa, and Asia-Pacific each demand tailored commercialization, supply, and service strategies

Regional dynamics shape both demand patterns and competitive positioning across the global endoscopy landscape. In the Americas, provider consolidation, reimbursement structures, and an emphasis on value-based care drive interest in solutions that reduce total procedural cost while improving diagnostic yield. Adoption is influenced by regulatory expectations around safety and traceability, as well as by a concentrated base of large hospital systems and ambulatory networks that set procurement standards. Consequently, companies that offer integrated service models and clear infection-control advantages tend to gain traction in procurement discussions.

Europe, Middle East & Africa presents a heterogeneous environment where regulatory frameworks, reimbursement pathways, and infrastructure maturity vary significantly across countries. In several markets, robust public healthcare procurement processes elevate the importance of long-term service agreements and compliance credentials. Elsewhere, demand growth hinges on expanding access to minimally invasive care and upgrades to diagnostic infrastructure. Manufacturers must navigate diverse regulatory regimes while tailoring market access strategies to local procurement cycles and clinical training initiatives.

Asia-Pacific exhibits accelerated adoption driven by capacity expansion, increased procedural volumes, and investments in medical infrastructure. A growing domestic manufacturing base in parts of the region enhances local supply options, and rapid uptake of new technologies frequently follows strong clinical advocacy and targeted training programs. Across all regions, differences in procurement cadence, clinical practice patterns, and regulatory timelines require nuanced commercialization strategies that balance global product platforms with localized service and supply commitments.

Competitive strategies reveal how product differentiation, integrated service models, and digital enablement are shaping vendor positioning and partnership activity

Competitive behavior among device manufacturers and service providers centers on three core propositions: product performance differentiation, service and sterilization capability, and digital enablement. Leading firms invest in next-generation optics, ergonomics, and channel versatility to improve diagnostic yield and procedural efficiency. They also expand service footprints and reprocessing solutions to address provider concerns about throughput, compliance, and lifecycle management. This combined hardware-plus-service approach strengthens customer relationships and creates recurring revenue through maintenance contracts and consumable supply agreements.

A parallel strategic thrust focuses on software and analytics. Companies that integrate image enhancement tools, workflow orchestration, and case management platforms differentiate by delivering measurable gains in clinician productivity and diagnostic consistency. Partnerships with software specialists and clinical research organizations underpin these moves and accelerate time-to-value. Additionally, several competitors are broadening their portfolios through strategic alliances, targeted acquisitions, and joint go-to-market agreements to secure access to complementary technologies and expand distribution reach.

Finally, sustainability and environmental considerations are emerging as differentiators. Organizations that demonstrate life-cycle thinking-addressing device recyclability, reprocessing efficiency, and waste reduction-gain favor with purchasers that have institutional sustainability mandates. Competitive advantage accrues to companies that combine credible environmental initiatives with clear clinical and economic benefits.

Practical strategic actions for manufacturers and health system leaders to protect supply chains, accelerate clinical adoption, and create enduring commercial advantage

Industry leaders should prioritize a set of concrete actions that translate strategic insight into measurable outcomes. First, diversify sourcing and supply-chain strategies to reduce exposure to trade policy disruptions and to shorten lead times for key components. Near-shoring or dual-sourcing critical modules can preserve agility and protect against sudden tariff or logistics shocks. Second, accelerate development and clinical validation of solutions that address infection prevention and reprocessing efficiency, as these attributes increasingly influence procurement decisions across care settings.

Third, invest in software-enabled differentiation that complements hardware innovation; deploying analytics and workflow tools increases clinical utility and creates recurring revenue opportunities. Fourth, refine commercial models to align with buyer priorities: offer bundled service agreements, outcome-linked contracts, and scalable pricing that reflect the total cost of ownership for differing facility types. Fifth, strengthen relationships with ambulatory surgical centers and clinics through targeted training, service packages, and financing options to drive adoption outside tertiary hospitals. Sixth, engage proactively with regulators and key opinion leaders to streamline approvals and build clinical evidence that demonstrates safety, efficacy, and economic benefit. Finally, incorporate environmental lifecycle management into product design and corporate strategy to meet emerging sustainability expectations without compromising clinical performance.

Taken together, these actions help manufacturers and providers mitigate risk, seize adoption opportunities, and build resilient, differentiated propositions that match the evolving needs of clinicians and healthcare systems.

Robust mixed-method research combining primary clinical and procurement interviews with rigorous secondary analysis and iterative expert validation

The research underpinning this executive summary combined structured primary engagement with domain experts, systematic review of clinical literature and regulatory guidance, and triangulation of supplier and provider data to validate findings. Primary inputs included interviews with practicing clinicians, procurement leaders at hospitals and ambulatory centers, and senior executives in device manufacturing and distribution. These conversations informed qualitative assessments of adoption drivers, clinical constraints, and procurement priorities.

Secondary research synthesized peer-reviewed clinical studies, regulatory announcements, and technical standards that govern device design and cleaning protocols. Where appropriate, comparative product assessments and case studies were used to illustrate performance differentials, while attention to public policy and trade updates framed assessment of supply-chain risks. Findings were validated through iterative review cycles with external clinical advisors and industry practitioners to ensure practical relevance and factual accuracy. Limitations include variability in regional regulatory timelines and heterogeneity of procurement practices across facility types; the methodology addresses these by applying conservative extrapolation and by noting context-specific constraints within the analysis.

Quality assurance steps included cross-checking interview insights against documented device specifications and reprocessing standards, and confirming thematic consistency across multiple data sources. The research approach emphasizes actionable synthesis over purely quantitative projection, aiming to equip decision-makers with defensible evidence and clear strategic implications.

Concluding synthesis highlighting how alignment of clinical innovation, reglementary compliance, and resilient commercialization will determine long-term success in endoscopy

The current era of endoscopy is defined by a balance of opportunity and constraint. Technological advances in imaging, device design, and digital analytics expand clinical capability and open routes to improved diagnostic accuracy. At the same time, safety concerns, regulatory scrutiny, and trade policy shifts place a premium on supply-chain resilience, lifecycle thinking, and service excellence. Providers and manufacturers that proactively align product innovation with operational realities-particularly reprocessing capacity, procedural throughput, and regional procurement practices-will realize the greatest adoption gains.

Success depends on integrating clinical insight with pragmatic commercial strategies: design devices for the actual workflows of ambulatory centers, clinics, and hospitals; pair hardware with software and service offerings that demonstrate clear value; and build flexible sourcing models that withstand policy and logistics variability. Those who act now to reconcile clinical benefits with procurement and regulatory demands will be best positioned to capture emerging opportunities and to lead the next phase of endoscopy advancement. In short, the path forward rewards organizations that blend technical excellence with operational foresight and strong customer partnerships.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Endoscopy Market, by Endoscope Type

  • 8.1. Flexible Endoscopes
    • 8.1.1. Bronchoscopes
    • 8.1.2. Colonoscopes
    • 8.1.3. Cystoscopes
    • 8.1.4. Duodenoscopes
    • 8.1.5. Gastroscopes
  • 8.2. Rigid Endoscopes
    • 8.2.1. Arthroscopes
    • 8.2.2. Hysteroscopes
    • 8.2.3. Laparoscopes

9. Endoscopy Market, by Usability

  • 9.1. Disposable
  • 9.2. Reusable

10. Endoscopy Market, by Imaging Technology

  • 10.1. Fiber Optic Endoscopy
  • 10.2. Video Endoscopy

11. Endoscopy Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Clinics
  • 11.3. Hospitals

12. Endoscopy Market, by Application

  • 12.1. Gastrointestinal
  • 12.2. Gynecological
  • 12.3. Respiratory
  • 12.4. Urological

13. Endoscopy Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Endoscopy Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Endoscopy Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Endoscopy Market

17. China Endoscopy Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Ambu A/S
  • 18.6. Arthrex, Inc.
  • 18.7. B. Braun Melsungen AG
  • 18.8. Boston Scientific Corporation
  • 18.9. CONMED Corporation
  • 18.10. Cook Medical LLC
  • 18.11. FUJIFILM Holdings Corporation
  • 18.12. Hoya Corporation
  • 18.13. Intuitive Surgical, Inc.
  • 18.14. Johnson & Johnson
  • 18.15. KARL STORZ SE & Co. KG
  • 18.16. Medtronic plc
  • 18.17. Mindray Medical International Limited
  • 18.18. Olympus Corporation
  • 18.19. Pentax Medical Company
  • 18.20. Richard Wolf GmbH
  • 18.21. Smith & Nephew plc
  • 18.22. STERIS Corporation
  • 18.23. Stryker Corporation
  • 18.24. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ENDOSCOPY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ENDOSCOPY MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ENDOSCOPY MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ENDOSCOPY MARKET SIZE, BY ENDOSCOPE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ENDOSCOPY MARKET SIZE, BY USABILITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ENDOSCOPY MARKET SIZE, BY IMAGING TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ENDOSCOPY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ENDOSCOPY MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ENDOSCOPY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ENDOSCOPY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL ENDOSCOPY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES ENDOSCOPY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA ENDOSCOPY MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ENDOSCOPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ENDOSCOPY MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ENDOSCOPY MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ENDOSCOPY MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ENDOSCOPY MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ENDOSCOPY MARKET SIZE, BY FLEXIBLE ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ENDOSCOPY MARKET SIZE, BY BRONCHOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ENDOSCOPY MARKET SIZE, BY BRONCHOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ENDOSCOPY MARKET SIZE, BY BRONCHOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ENDOSCOPY MARKET SIZE, BY COLONOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ENDOSCOPY MARKET SIZE, BY COLONOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ENDOSCOPY MARKET SIZE, BY COLONOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ENDOSCOPY MARKET SIZE, BY CYSTOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ENDOSCOPY MARKET SIZE, BY CYSTOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ENDOSCOPY MARKET SIZE, BY CYSTOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ENDOSCOPY MARKET SIZE, BY DUODENOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ENDOSCOPY MARKET SIZE, BY DUODENOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ENDOSCOPY MARKET SIZE, BY DUODENOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ENDOSCOPY MARKET SIZE, BY GASTROSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ENDOSCOPY MARKET SIZE, BY GASTROSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ENDOSCOPY MARKET SIZE, BY GASTROSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ENDOSCOPY MARKET SIZE, BY RIGID ENDOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ENDOSCOPY MARKET SIZE, BY RIGID ENDOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ENDOSCOPY MARKET SIZE, BY RIGID ENDOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ENDOSCOPY MARKET SIZE, BY RIGID ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ENDOSCOPY MARKET SIZE, BY ARTHROSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ENDOSCOPY MARKET SIZE, BY ARTHROSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ENDOSCOPY MARKET SIZE, BY ARTHROSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ENDOSCOPY MARKET SIZE, BY HYSTEROSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ENDOSCOPY MARKET SIZE, BY HYSTEROSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ENDOSCOPY MARKET SIZE, BY HYSTEROSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ENDOSCOPY MARKET SIZE, BY LAPAROSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ENDOSCOPY MARKET SIZE, BY LAPAROSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ENDOSCOPY MARKET SIZE, BY LAPAROSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ENDOSCOPY MARKET SIZE, BY USABILITY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ENDOSCOPY MARKET SIZE, BY DISPOSABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ENDOSCOPY MARKET SIZE, BY DISPOSABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ENDOSCOPY MARKET SIZE, BY DISPOSABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ENDOSCOPY MARKET SIZE, BY REUSABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ENDOSCOPY MARKET SIZE, BY REUSABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ENDOSCOPY MARKET SIZE, BY REUSABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ENDOSCOPY MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ENDOSCOPY MARKET SIZE, BY FIBER OPTIC ENDOSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ENDOSCOPY MARKET SIZE, BY FIBER OPTIC ENDOSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ENDOSCOPY MARKET SIZE, BY FIBER OPTIC ENDOSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ENDOSCOPY MARKET SIZE, BY VIDEO ENDOSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ENDOSCOPY MARKET SIZE, BY VIDEO ENDOSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ENDOSCOPY MARKET SIZE, BY VIDEO ENDOSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ENDOSCOPY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ENDOSCOPY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ENDOSCOPY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ENDOSCOPY MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ENDOSCOPY MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ENDOSCOPY MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ENDOSCOPY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ENDOSCOPY MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ENDOSCOPY MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ENDOSCOPY MARKET SIZE, BY GASTROINTESTINAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ENDOSCOPY MARKET SIZE, BY GASTROINTESTINAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ENDOSCOPY MARKET SIZE, BY GASTROINTESTINAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ENDOSCOPY MARKET SIZE, BY GYNECOLOGICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ENDOSCOPY MARKET SIZE, BY GYNECOLOGICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ENDOSCOPY MARKET SIZE, BY GYNECOLOGICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ENDOSCOPY MARKET SIZE, BY RESPIRATORY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ENDOSCOPY MARKET SIZE, BY RESPIRATORY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ENDOSCOPY MARKET SIZE, BY RESPIRATORY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ENDOSCOPY MARKET SIZE, BY UROLOGICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ENDOSCOPY MARKET SIZE, BY UROLOGICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL ENDOSCOPY MARKET SIZE, BY UROLOGICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL ENDOSCOPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS ENDOSCOPY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS ENDOSCOPY MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS ENDOSCOPY MARKET SIZE, BY FLEXIBLE ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS ENDOSCOPY MARKET SIZE, BY RIGID ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS ENDOSCOPY MARKET SIZE, BY USABILITY, 2018-2032 (USD MILLION)
  • TABLE 78. AMERICAS ENDOSCOPY MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA ENDOSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA ENDOSCOPY MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA ENDOSCOPY MARKET SIZE, BY FLEXIBLE ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA ENDOSCOPY MARKET SIZE, BY RIGID ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA ENDOSCOPY MARKET SIZE, BY USABILITY, 2018-2032 (USD MILLION)
  • TABLE 86. NORTH AMERICA ENDOSCOPY MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA ENDOSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA ENDOSCOPY MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. LATIN AMERICA ENDOSCOPY MARKET SIZE, BY FLEXIBLE ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA ENDOSCOPY MARKET SIZE, BY RIGID ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA ENDOSCOPY MARKET SIZE, BY USABILITY, 2018-2032 (USD MILLION)
  • TABLE 94. LATIN AMERICA ENDOSCOPY MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPY MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPY MARKET SIZE, BY FLEXIBLE ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPY MARKET SIZE, BY RIGID ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPY MARKET SIZE, BY USABILITY, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPY MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE ENDOSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE ENDOSCOPY MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE ENDOSCOPY MARKET SIZE, BY FLEXIBLE ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE ENDOSCOPY MARKET SIZE, BY RIGID ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE ENDOSCOPY MARKET SIZE, BY USABILITY, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE ENDOSCOPY MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST ENDOSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST ENDOSCOPY MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. MIDDLE EAST ENDOSCOPY MARKET SIZE, BY FLEXIBLE ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST ENDOSCOPY MARKET SIZE, BY RIGID ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 117. MIDDLE EAST ENDOSCOPY MARKET SIZE, BY USABILITY, 2018-2032 (USD MILLION)
  • TABLE 118. MIDDLE EAST ENDOSCOPY MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 119. MIDDLE EAST ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 120. MIDDLE EAST ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 121. AFRICA ENDOSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. AFRICA ENDOSCOPY MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. AFRICA ENDOSCOPY MARKET SIZE, BY FLEXIBLE ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 124. AFRICA ENDOSCOPY MARKET SIZE, BY RIGID ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 125. AFRICA ENDOSCOPY MARKET SIZE, BY USABILITY, 2018-2032 (USD MILLION)
  • TABLE 126. AFRICA ENDOSCOPY MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 127. AFRICA ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 128. AFRICA ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC ENDOSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC ENDOSCOPY MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC ENDOSCOPY MARKET SIZE, BY FLEXIBLE ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC ENDOSCOPY MARKET SIZE, BY RIGID ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC ENDOSCOPY MARKET SIZE, BY USABILITY, 2018-2032 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC ENDOSCOPY MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL ENDOSCOPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 138. ASEAN ENDOSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. ASEAN ENDOSCOPY MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. ASEAN ENDOSCOPY MARKET SIZE, BY FLEXIBLE ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 141. ASEAN ENDOSCOPY MARKET SIZE, BY RIGID ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 142. ASEAN ENDOSCOPY MARKET SIZE, BY USABILITY, 2018-2032 (USD MILLION)
  • TABLE 143. ASEAN ENDOSCOPY MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 144. ASEAN ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. ASEAN ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 146. GCC ENDOSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. GCC ENDOSCOPY MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. GCC ENDOSCOPY MARKET SIZE, BY FLEXIBLE ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 149. GCC ENDOSCOPY MARKET SIZE, BY RIGID ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 150. GCC ENDOSCOPY MARKET SIZE, BY USABILITY, 2018-2032 (USD MILLION)
  • TABLE 151. GCC ENDOSCOPY MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 152. GCC ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 153. GCC ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPEAN UNION ENDOSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPEAN UNION ENDOSCOPY MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPEAN UNION ENDOSCOPY MARKET SIZE, BY FLEXIBLE ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPEAN UNION ENDOSCOPY MARKET SIZE, BY RIGID ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPEAN UNION ENDOSCOPY MARKET SIZE, BY USABILITY, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPEAN UNION ENDOSCOPY MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPEAN UNION ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPEAN UNION ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 162. BRICS ENDOSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. BRICS ENDOSCOPY MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. BRICS ENDOSCOPY MARKET SIZE, BY FLEXIBLE ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 165. BRICS ENDOSCOPY MARKET SIZE, BY RIGID ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 166. BRICS ENDOSCOPY MARKET SIZE, BY USABILITY, 2018-2032 (USD MILLION)
  • TABLE 167. BRICS ENDOSCOPY MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 168. BRICS ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 169. BRICS ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 170. G7 ENDOSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 171. G7 ENDOSCOPY MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. G7 ENDOSCOPY MARKET SIZE, BY FLEXIBLE ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 173. G7 ENDOSCOPY MARKET SIZE, BY RIGID ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 174. G7 ENDOSCOPY MARKET SIZE, BY USABILITY, 2018-2032 (USD MILLION)
  • TABLE 175. G7 ENDOSCOPY MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 176. G7 ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 177. G7 ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 178. NATO ENDOSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 179. NATO ENDOSCOPY MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. NATO ENDOSCOPY MARKET SIZE, BY FLEXIBLE ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 181. NATO ENDOSCOPY MARKET SIZE, BY RIGID ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 182. NATO ENDOSCOPY MARKET SIZE, BY USABILITY, 2018-2032 (USD MILLION)
  • TABLE 183. NATO ENDOSCOPY MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 184. NATO ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 185. NATO ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 186. GLOBAL ENDOSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 187. UNITED STATES ENDOSCOPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 188. UNITED STATES ENDOSCOPY MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. UNITED STATES ENDOSCOPY MARKET SIZE, BY FLEXIBLE ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 190. UNITED STATES ENDOSCOPY MARKET SIZE, BY RIGID ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 191. UNITED STATES ENDOSCOPY MARKET SIZE, BY USABILITY, 2018-2032 (USD MILLION)
  • TABLE 192. UNITED STATES ENDOSCOPY MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 193. UNITED STATES ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 194. UNITED STATES ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 195. CHINA ENDOSCOPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 196. CHINA ENDOSCOPY MARKET SIZE, BY ENDOSCOPE TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. CHINA ENDOSCOPY MARKET SIZE, BY FLEXIBLE ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 198. CHINA ENDOSCOPY MARKET SIZE, BY RIGID ENDOSCOPES, 2018-2032 (USD MILLION)
  • TABLE 199. CHINA ENDOSCOPY MARKET SIZE, BY USABILITY, 2018-2032 (USD MILLION)
  • TABLE 200. CHINA ENDOSCOPY MARKET SIZE, BY IMAGING TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 201. CHINA ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 202. CHINA ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)